Top in endocrinology: Tailored weight-loss therapy, vasomotor symptoms in menopause

Recent data revealed that individually targeted obesity interventions guided by phenotypes can double weight loss compared with usual care. This was the top story in endocrinology last week.

Another top story was about an association between TACR3 and a reduced odds of frequent vasomotor symptoms among white women during menopause.

Read these and more top stories in endocrinology below:

Novel obesity classifications can aid in tailoring weight-loss treatments

Phenotype-guided obesity interventions, determined by a blood test, can double weight loss for patients compared with standard obesity care, according to a presenter at the Obesity Medicine Association 2021 virtual conference. Read more.

Genetic variants predict vasomotor symptom frequency in menopause

Some genetic factors associated with reproductive aging are also predictive of the frequency of vasomotor symptoms, according to a study published in Menopause. Read more.

‘Be inefficient’ mindset may help adults with obesity achieve healthy body weight

Adults with obesity may have more success with weight loss by engaging in inefficient behaviors, according to a presenter at the Obesity Medicine Association 2021 virtual conference. Read more.

High blood glucose at admission, insulin use raise risk for COVID-19 mortality in diabetes

People with diabetes who have elevated blood glucose levels at admission and those who take insulin are at increased risk for COVID-19 mortality, according to data from a systematic review and meta-analysis published in Diabetologia. Read more.

Polygenic risk score may improve screening for short stature risk in adulthood

A polygenic risk score can predict adult short stature among children with accuracy similar to the use of midparental height, according to data published in The Journal of Clinical Endocrinology & Metabolism. Read more.